Douglas Olsen, MD
Family Medicine · Hilo, HINPI 1235273616
Payments from drug & device makers
Across 680 payments — averaging $19.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$2K
- Amgen$2K
- AbbVie$2K
- AstraZeneca$2K
- Pfizer$891
- GSK$775
- plus $5K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 76 | $1,892 |
| Amgen(2 entities) | 79 | $1,768 |
| AbbVie(2 entities) | 81 | $1,564 |
| AstraZeneca | 54 | $1,559 |
| Pfizer | 53 | $891 |
| GSK | 74 | $775 |
| Novo Nordisk | 43 | $682 |
| Lilly USA, LLC | 31 | $550 |
| Takeda Pharmaceuticals U.S.A., Inc. | 35 | $476 |
| Lundbeck LLC | 22 | $401 |
| Amarin Pharma, Inc. | 19 | $394 |
| Kowa Pharmaceuticals America, Inc. | 24 | $393 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 14 | $329 |
| Sanofi-aventis U.S. LLC | 12 | $238 |
| Merck | 9 | $237 |
| Otsuka America Pharmaceutical, Inc. | 10 | $229 |
| Eisai Inc. | 6 | $123 |
| Bayer | 5 | $117 |
| Esperion Therapeutics, Inc. | 5 | $110 |
| Axsome Therapeutics, Inc. | 3 | $82 |
| Johnson & Johnson | 3 | $56 |
| Exact Sciences | 3 | $53 |
| Radius Health, Inc. | 2 | $53 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $50 |
| Vanda Pharmaceuticals Inc. | 2 | $49 |
| Sanofi | 2 | $46 |
| Novartis | 2 | $39 |
| Inspire Medical Systems, Inc. | 1 | $37 |
| Genentech USA, Inc. | 2 | $35 |
| E.r. Squibb & Sons, L.L.C. | 1 | $28 |
| Ironwood Pharmaceuticals, Inc | 1 | $23 |
| Biohaven Pharmaceuticals, Inc. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $15 |
How this compares
$13,338 in reported general payments places this provider in the 95th percentile of 376 family medicine providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Hilo
- Buddy FesterlingHilo$20K
- Roy KogaHilo$20K
- Kara OkaharaHilo$9K
- Charles SonidoHilo$8K
- Matthew DykemaHilo$8K
- Richard Lee-ChingHilo$3K
- Gina Marie SalcedoHilo$3K
- Hugh MooreKoloa$237K
- Brian StolleyKihei$126K
- Vicente RamoHonolulu$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.